LifeArc Philanthropic Fund
Provides Translational grants for United academic rare disease researchers with IP and a route to patient.
LifeArc's Philanthropic Fund was a translational route for UK academic researchers working on rare disease therapeutics, devices, or diagnostics. It is paused now and not accepting applications, but the historic record is still useful because it shows the level of ambition LifeArc expected from this channel. Awards historically ranged from £146,781 to £811,582, with panels meeting in December and June. By December 2022, the fund had awarded £14.6 million across 45 projects covering 33 rare disease indications. When active, the eligibility bar was clear: UK academic researchers only, strong scientific rationale, a target-driven delivery plan, a route to patient, and either existing or secured intellectual property rights for commercialisation. The fund consistently favoured projects that were already close enough to translation to justify detailed review, rather than speculative discovery work. Because it is paused with no reopening date announced, applicants should treat it as a closed historical mechanism and look to LifeArc's current rare disease routes for live opportunities.
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.